Roximax Plus 500 mg Tab.
Generic Name: Cefuroxime Axetil USP + Clavulanic Acid BP
| Therapeutic Class |
Antibiotic |
|---|
Presentation
Roximax Plus 500 Tablet: Each ¬lm coated tablet contains Cefuroxime 500 mg as Cefuroxime Axetil USP and Clavulanic Acid 125 mg as Diluted Potassium Clavulanate BP.
Indications
- Pharyngitis / tonsillitis caused by Streptococcus pyogenes
- Acute bacterial otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Moraxella catarrhalis (including beta lactamase- producing strains) or Streptococcus pyogenes.
- Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (Non beta lactamase producing strains only)
- Lower respiratory tract infections including pneumoniae caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase and non-penicillinase-producing strains), Streptococcus pyogenes, Escherichia coli
- Acute bacterial exacerbations of chronic bronchitis and secondary bacterial infections of acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains), or Haemophilus para-influenzae (beta-lactamase negative strains).
- Skin and Skin-Structure infections caused by Staphylococcus aureus (penicillinase and non-penicillinase-producing strains), Streptococcus pyogenes, Escherichia coli, Klebsiella spp., and Enterobacter spp.
- Urinary tract infections caused by Escherichia coli or Klebsiella pneumoniae.
- Bone and Joint infections caused by Staphylococcus aureus (penicillinase and non-penicillinase-producing strains).
- Gonorrhea Uncomplicated and disseminated gonococcal infections due to Neisseria gonorrhoeae (penicillinase and non penicillinase producing strains) in both males and females.
Dosage & Administration
- Adolescents and adults (13 years and older)-
- Pharyngitis/tonsillitis: 250 mg b.i.d. for 5-10 days
- Acute bacterial maxillary sinusitis: 250 mg b.i.d. for 10 days
- Acute bacterial exacerbation of chronic bronchitis: 250-500 mg b.i.d. for 10 days
- Secondary bacterial infections of acute bronchitis: 250-500 mg b.i.d. for 5-10 days
- Uncomplicated skin and skin structure infections: 250-500 mg b.i.d. for 10 days
- Uncomplicated urinary tract infections: 250 mg b.i.d. for 7-10 days
- Uncomplicated Gonorrhoea: 1000 mg Single dose
- Community acquired pneumonia: 250-500 mg b.i.d. for 5-10 days
- MDR Typhoid Fever: 500 mg b.i.d. for 10-14 days
- Early Lyme disease: 500 mg b.i.d. for 20 days
Pediatric Patients (03 months to 12 years, who can swallow tablet whole):
- Acute Otitis Media: 250 mg b.i.d. for 10 days
- Acute Bacterial Maxillary Sinusitis: 250 mg b.i.d. for 10 days
Packaging
Roximax Plus 500 Tablet: Each box contains 1x7’s tablets in Alu-Alu blister pack.
